United States Biotechnology & Medical Research

Hoth Therapeutics Inc (HOTH)

Track

No active insider signal

Not featured in screeners

Featured in screeners

No active insider signal

Not featured in screeners

Ticker: HOTH Exchange: NAS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

Activity signals detected for Hoth Therapeutics Inc

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Hoth Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

2.9

Knie Robb CEO and President Executive Director

Transaction date 16 Aug 2024

Purchase

Price

237.87

Quantity 9,883 +30.7%

Value US$4,119,944

2.9

Knie Robb CEO and President Executive Director

Transaction date 19 Sep 2022

Purchase

Price

101.90

Quantity 1,281 -38.5%

Value US$1,784,618

2.9

Knie Robb CEO and President Executive Director

Transaction date 16 Sep 2022

Purchase

Price

175.47

Quantity 86,595 +34.3%

Value US$4,713,023

2.6

Hayes Anthony Large shareholder

Transaction date 26 May 2020

Sale

Price

1.25

Quantity 400,000 -26.1%

Value US$500,000

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-08-19	2024-08-16	B Purchase	2.9 Knie Robb CEO and President Executive Director	9,883 +30.7% 237.87 US$4,119,944	9,883 +30.7%	237.87	US$4,119,944
2022-09-20	2022-09-19	B Purchase	2.9 Knie Robb CEO and President Executive Director	1,281 -38.5% 101.90 US$1,784,618	1,281 -38.5%	101.90	US$1,784,618
2022-09-19	2022-09-16	B Purchase	2.9 Knie Robb CEO and President Executive Director	86,595 +34.3% 175.47 US$4,713,023	86,595 +34.3%	175.47	US$4,713,023
2020-05-29	2020-05-26	S Sale	2.6 Hayes Anthony Large shareholder	400,000 -26.1% 1.25 US$500,000	400,000 -26.1%	1.25	US$500,000